Introduction
============

Obesity is a very common condition worldwide. Between 1980 and 2013, the proportion of over-weigh adults and those with obesity increased from 28.8% to 36.9% in men, and from 29.8% to 38.0% in women.[@b1-ARYA-16-016]

The rising trend of obesity in many countries led to very serious consequences at both individual and community levels.[@b2-ARYA-16-016] Obesity is an independent and modifiable risk factor for all-cause mortality including cardiovascular disease (CVD) related mortality rates.[@b3-ARYA-16-016]-[@b5-ARYA-16-016] However, some recent studies have reported an inverse association between obesity and CVD risk, heart failure related mortality rate, myocardial infarction (MI) outcomes, and the consequences of CVD events interventions; this inverse association was named the obesity paradox.[@b6-ARYA-16-016],[@b7-ARYA-16-016]

CVD risk assessment tools have been utilized to estimate the 10-year risk of CVD for years. In these tools, several modifiable and non-modifiable risk factors of CVD are utilized to predict the 10-year risk of CVD. The pooled cohort equations of the American College of Cardiology/American Heart Association (ACC/AHA) and the Framingham general cardiovascular risk proﬁle (for use in primary care) were developed using some CVD risk factors including age, history of diabetes mellitus (DM), current smoking status, systolic blood pressure (SBP), total cholesterol and high density lipoprotein (HDL) in men and women, separately.[@b8-ARYA-16-016],[@b9-ARYA-16-016]

Two versions of the Systematic Coronary Risk Evaluation (SCORE) equations were also developed according to the abovementioned risk factors, except for HDL and history of DM.[@b10-ARYA-16-016] None of the obesity indices are utilized in the abovementioned CVD risk assessment tools, Although, there are several simple indices to evaluate obesity, none of the obesity indices are utilized to predict the 10-year CVD risk in the abovementioned CVD risk assessment tools. Since the obesity paradox was confirmed for some CVD outcomes based on some obesity indices, particularly BMI, we aimed to determine whether the obesity paradox would be detectable when the 10-year risk of CVD and obesity are determined by mentioned risk assessment tools and obesity indices, respectively.

Materials and Methods
=====================

The present cohort study was conducted among 6140 subjects aged 10-90 years in northern Iran (Amol) in 2009-2010. We obtained the study sampling frame from health centers, where all residents had a health record file. The population of the city was categorized into 16 categories based on sex and age at the intervals of 10 years. We randomly selected the study participants from each category based on the proportion to size approach. All study arrangements were in accordance with the Helsinki Declaration. Informed consent was obtained from all study subjects, and the study was approved by the Ethics Committee of Iran University of Medical Sciences, Iran. Since the risk assessment tools are generally applied to the population aged 40-74 years (8-10), the data of 2910 subjects (1623 men and 1287 women) aged 40-74 years were utilized in this study. The study population and the study inclusion and exclusion criteria are displayed in [figure 1](#f1-ARYA-16-016){ref-type="fig"}.

Anthropometric data and BP were measured by trained health care providers for each participant. The participants' weight was measured without excess clothes and shoes. Their height was measured while they stood upright with their heels and buttocks in contact with the wall. The midpoint of the distance between the lowest costal ridge and the upper border of the iliac crest was considered as the waist circumference (WC). The largest circumference between the waist and knee was considered the hip circumference (HC). The health care providers measured BP in sitting position using a fitted cuff, following at least 5 minutes of rest.

Lipid profiles and fasting blood sugar (FBS) were evaluated following 12 hours of fasting. All tests, including FBS and lipid profiles, were assessed enzymatically according to protocol using an autoanalyzer (BS200, Mindray, China).

To determine the 10-year risk of CVD in the present study, 4 risk assessment tools, including pooled cohort equations of the ACC/AHA, SCORE equations for low and high risk European countries, and the Framingham general cardiovascular risk proﬁle (for use in primary care), were used.[@b8-ARYA-16-016]-[@b10-ARYA-16-016] While the ACC/AHA equations and Framingham tool estimate fatal and non-fatal 10-year risk of CVD, SCORE equations only estimate the fatal risk.

We changed the estimated risks into dichotomous scales according to a cut off point of 0.075 (7.5%) for ACC/AHA, 0.05 (5%) for SCORE equations, and 0.1 (10%) for the Framingham tool (8-10). Receiver operating characteristic (ROC) curve was used to assess the capability of BMI, WC, waist to hip ratio (WHR), and waist to height ratio (WHtR) in the discrimination of people with a 10-year risk ≥ 5%, ≥ 7.5%, and ≥ 10% (according to the related thresholds of the abovementioned CVD risk assessment tools) from people with a lower risk. In ROC curves, the sensitivities of infinite thresholds of obesity measures were plotted versus the associated false positive rates. Consequently, the associated areas under the curves (AUCs) were computed. The lowest threshold for AUC was considered as 0.5, meaning a significantly greater area than 0.5 signifies the power of obesity indices to distinguish participants with a higher 10-year risk of CVD than related thresholds in participants without those indices.

Furthermore, the values of obesity indices were categorized into dichotomous variables according to related data in previous literature. Thus, BMI was classified into a dichotomous variable based on a cut off point of 30 kg/m2 in women and men, WC was categorized based on a cut off point of 88 cm in women and 102 cm in men, WHR was categorized based on a cut off point of 0.85 in women and 0.9 in men, and WHtR was categorized based on a cut off point of 0.5 in women and men.[@b11-ARYA-16-016]-[@b13-ARYA-16-016] Obesity was defined based on the abovementioned thresholds of each related obesity indice, and the 10-year risk of CVD was estimated in participants with and without obesity. The proportion of individuals who had a 10-year risk of CVD ≥ 7.5% based on ACC/AHA, ≥ 5% based on SCORE equations (low and high risk European countries), and ≥ 10% based on Framingham approach were compared between the groups with and without obesity using independent two group proportion test. Since the 10-year risk of CVD was estimated based on 4 risk assessment tools and obesity was determined according to 4 indices, 16 two group proportion tests were performed in men and women, separately.

Finally, several logistic regression analyses were separately performed in which each of the categorized obesity indices was considered a predictor and a 10-year risk of CVD ≥ 7.5%, ≥ 5%, and ≥ 10% was considered an outcome based on pooled cohort equations, SCORE equations, and the Framingham tool, respectively. In multiple logistic regression analyses, in addition to the evaluated obesity indices, LDL-C level, TG level, and diastolic blood pressure (DBP) were entered into the associated models. It is worth noting that these risk factors are not directly utilized in risk assessment tools to compute the 10-year risk of CVD.

A threshold of 0.05 (less than 0.05) was taken into account as the significance level for all analyses. All analyses were performed using Stata software (version 12; StataCorp, Texas, USA).

Results
=======

The demographic characteristics of the participants are presented in [table 1](#t1-ARYA-16-016){ref-type="table"}. The prevalence of diabetes in women was significantly higher than men (26.01% vs 13.4%; P \< 0.0001). While the percentage of current smoking was 30.2% in men, it was only 0.84% in women (P \< 0.0001).

[Table 2](#t2-ARYA-16-016){ref-type="table"} shows the percentage of study population who had a 10-year risk of CVD ≥ 7.5%, ≥ 5%, ≥ 5%, and ≥10% according to pooled cohort equations of ACC/AHA, SCORE equations for low risk European countries, SCORE equations for high risk European countries, and the Framingham general cardiovascular risk proﬁle in men and women with and without obesity, respectively.

The categorization of individuals to with obesity and without obesity according to BMI showed that a higher proportion of women without obesity had a 10-year risk of CVD ≥ 7.5% compared to women with obesity based on the ACC/AHA equations (28.54% vs. 24.15%), although the difference was not statistically significant (P = 0.0707).

[Table 3](#t3-ARYA-16-016){ref-type="table"} shows the results of the univariate logistic regression analysis in which obesity indices were separately considered as predictors and 10-year risk of CVD ≥ 7.5%, ≥ 5%, and ≥ 10% were considered outcomes based on pooled cohort equations, SCORE equations, and the Framingham tool, respectively. According to these results, WHR and WHtR had a significant relationship with estimated 10-year risk of CVD in all risk assessment tools. Furthermore, WHR showed the strongest relationships with 10-year risk of CVD compared to other obesity indices, particularly in women. In multiple logistic regression analysis with the elimination of the effects of other risk factors, which were applied to calculate 10-year risk of CVD, none of the obesity indices showed a significant association with the related 10-year risk of CVD.

The present study results showed that BMI had a non-significant AUC (\< 0.5) based on pooled cohort equations of ACC/AHA tool \[0.4742 (0.4391-0.5093)\] and SCORE equations for high-risk European countries \[0.4717 (0.4022-0.5412)\] in women.

Discussion
==========

The present study was conducted to determine whether the obesity paradox will be detectable when 10-year risk of CVD and obesity are determined by related risk assessment tools and obesity indices, respectively.

The results showed a weak and non-significant obesity paradox in women whose obesity and 10-year risk of CVD were determined based on BMI and ACC/AHA equation, respectively. A lower proportion (but non-significant) of women with obesity, based on a BMI ≥ 30, had a10-year risk of CVD ≥ 7.5% compared to women without obesity when the ACC/AHA equation was applied. BMI had the lowest discriminatory ability among the mentioned obesity indices. The discriminatory ability of BMI was even less than 0.5 in women whose 10-year risk of CVD was estimated based on pooled cohort equations of ACC/AHA and SCORE equations for high risk European countries.

McAuley et al. showed that obesity (BMI ≥ 30) was related to a lower mortality risk in a clinical population of individuals without heart failure, which was in agreement with the obesity paradox.[@b7-ARYA-16-016] While a high WHR is primarily associated with increased central fat stores (notably with visceral fat), decreased thigh muscle mass, and reduced physical fitness, a high BMI is associated with increased thigh muscle mass and peripheral fat stores without association with visceral fat.[@b14-ARYA-16-016] A growing body of evidence still supports purposeful weight reduction in the control and treatment of CVDs.[@b15-ARYA-16-016] Moreover, it has been suggested that the obesity paradox is largely confounded by fitness.

Consequently, individuals who are more fit usually have a better prognosis than others, and no clear obesity paradox is apparent in these individuals.[@b7-ARYA-16-016]

Some theories attempted to explain the protective effect of obesity by altered cytokines, plasma rennin, epinephrine, and larger coronary arteries.[@b16-ARYA-16-016] Some other studies proposed smoking as a confounding variable in the obesity paradox; smokers usually lose weight and they also have a higher risk of CVD.[@b16-ARYA-16-016]-[@b18-ARYA-16-016] However, in the present study, the obesity paradox was weakly confirmed only in women and only 0.84% of them were currently smoking, suggesting that smoking might not play a critical role in this context.

Although no obesity indices showed a relationship with 10-year risk of CVD in a multivariate model, WHR had the strongest association with 10-year risk of CVD in a univariate binary regression model. Previous studies showed that WC and HC have an independent relationship with MI. Consequently, it is reasonable that a combined measure of these two indices (such as WHR) has a strong association with CVD events, as the present study results suggested. An inverse association was observed between HC and risk of DM, hypertension (HTN), dyslipidemia, and CVD.[@b19-ARYA-16-016]-[@b22-ARYA-16-016] Furthermore, DM, HTN, and lipid profiles are the variables commonly utilized to estimate the 10-year risk of CVD. From a different perspective, estrogens have an important role in the accumulation of subcutaneous gluteal and femoral fat, and a higher WHR indicates decreased muscle mass in the legs and gluteal region.[@b21-ARYA-16-016] Furthermore, the protective effect of estrogen on the cardiovascular system was emphasized in a previous study.[@b23-ARYA-16-016] Thus, it is reasonable to assume that a higher WHR, which is usually associated with a lower estrogen level, can lead to a higher CVD risk.

This study had some limitations. Although we utilized 4 popular risk assessment tools, none of these risk assessment tools were developed for our country. However, similar results particularly in the context of the association between obesity indices and CVD risk may approve the validity of our findings. In addition, a weak inverse relationship between BMI and estimated CVD risk is not equal to the inverse association between BMI and CVD events. However, this can signify that there is at least a non-strong, negative relationship between BMI as a general index of obesity and a cluster of CVD risk factors that may lead to CVD events in the next decade.

Conclusion
==========

BMI showed a weak and non-significant inverse association with 10-year risk of CVD estimated by pooled cohort equations of ACC/AHA in women. However, this result cannot directly provide enough evidence for the obesity paradox.
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###### 

Characteristics and clinical biomarkers of the study participants (n = 2910)

  Characteristics             Men (n = 1623)    Women (n = 1287)   P[\*](#tfn1-ARYA-16-016){ref-type="table-fn"}
  --------------------------- ----------------- ------------------ -----------------------------------------------
  Age (year)                  53.91 ± 9.36      53.50 ± 9.01       0.1890
  BMI (kg/m^2^)               27.23 ± 4.27      31.23 ± 5.04       \< 0.0010
  WC (cm)                     93.54 ± 11.23     96.20 ± 11.55      \< 0.0010
  WHR                         0.93 ± 0.07       0.89 ± 0.08        \< 0.0010
  WHtR                        0.56 ± 0.07       0.62 ± 0.08        \< 0.0010
  DBP (mm Hg)                 78.10 ± 13.15     79.32 ± 12.90      0.0080
  SBP (mm Hg)                 119.01 ± 16.87    120.93 ± 18.21     0.0020
  FBS (mg/dl)                 103.01 ± 34.86    113.16 ± 48.67     \< 0.0010
  TG (mg/dl)                  155.21 ± 100.19   159.04 ± 108.57    0.3080
  Total cholesterol (mg/dl)   187.13 ± 41.13    200.57 ± 43.28     \< 0.0010
  LDL (mg/dl)                 110.16 ± 30.61    117.48 ± 31.52     \< 0.0010
  HDL (mg/dl)                 42.83 ± 11.61     44.67 ± 12.01      0.0010

Significance level was considered at P \< 0.0500.

SD: Standard deviation; BMI: Body mass index; WC: Waist circumference; WHR: Waist to hip ratio; WHtR: Waist to height ratio; DBP: Diastolic blood pressure; SBP: Systolic blood pressure; FBS: Fasting blood sugar; TG: Triglyceride; LDL: Low-density lipoprotein; HDL: High-density lipoprotein

###### 

The proportion \[confidence interval (95%CI)\] of the study population who had a 10-years risk of cardiovascular disease (CVD) ≥ 7.5%, ≥ 5%, ≥ 5%, and ≥ 10% based on related risk assessment tools in individuals with and without obesity defined by different obesity indices

  Obesity indices (BMI)                                                                                                                             BMI \< 30 in men and women         BMI ≥ 30 in men and women         P[\*](#tfn4-ARYA-16-016){ref-type="table-fn"}       BMI \< 30 in men and women         BMI ≥ 30 in men and women         P[\*](#tfn4-ARYA-16-016){ref-type="table-fn"}
  ------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- --------------------------------- --------------------------------------------------- ---------------------------------- --------------------------------- ---------------------------------------------------
  A risk of ≥ 7.5% based on pooled cohort equations of ACC/AHA [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                                          54.46 (51.76-57.16)                62.04 (57.44-66.64)               0.0060                                              28.54 (24.77-32.32)                24.12 (21.13-27.11)               0.0710
  A risk of ≥ 5% based on SCORE equations for low risk European countries [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                               10.28 (8.66-11.90)                 10.47 (7.63-13.31)                0.9130                                              2.23 (1.03-3.43)                   2.03 (1.08-2.99)                  0.8030
  A risk of ≥ 5% based on SCORE equations for high risk European countries [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                              24.44 (22.15-26.73)                25.00 (20.99-29.01)               0.8140                                              5.49 (3.64-7.34)                   4.91 (3.44-6.38)                  0.6270
  A risk of ≥ 10% based on the Framingham general cardiovascular risk profile for use in primary care [£](#tfn3-ARYA-16-016){ref-type="table-fn"}   50.47 (47.76-53.18)                59.02 (54.35-63.68)               0.0020                                              21.62 (18.18-25.06)                21.86 (18.98-24.74)               0.9180
  **Obesity indices (WC)**                                                                                                                          **WC \< 102 in men**               **WC ≥ 102 in men**               **P[\*](#tfn4-ARYA-16-016){ref-type="table-fn"}**   **WC \< 88 in women**              **WC ≥ 88 in women**              **P[\*](#tfn4-ARYA-16-016){ref-type="table-fn"}**
  **Risk assessment tools**                                                                                                                         Men (n = 1623)                     Women (n = 1287)                                                                                                                                           
  A risk of ≥ 7.5% based on pooled cohort equations of ACC/AHA [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                                          52.95 (50.27-55.63)                67.55 (63.00-72.10)               \< 0.0010                                           18.32 (13.86-22.78)                27.90 (25.20-30.60)               0.0010
  A risk of ≥ 5% based on SCORE equations for low risk European countries [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                               9.73 (8.17-11.29)                  12.80 (9.61-15.98)                0.0710                                              1.66 (0.22-3.10)                   2.23 (1.37-3.09)                  0.5370
  A risk of ≥ 5% based on SCORE equations for high risk European countries [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                              22.75 (20.54-24.96)                30.80 (26.40-35.20)               0.0080                                              4.30 (2.01-6.59)                   5.35 (4.03-6.67)                  0.4640
  A risk of ≥ 10% based on the Framingham general cardiovascular risk profile for use in primary care [£](#tfn3-ARYA-16-016){ref-type="table-fn"}   48.74 (46.06-51.42)                65.34 (60.71-69.97)               \< 0.0010                                           12.46 (8.65-16.26)                 24.20 (21.62-26.78)               \< 0.0010
  **Obesity indices (WHR)**                                                                                                                         **WHR \< 0.9 in men**              **WHR ≥ 0.9 in men**              **P[\*](#tfn4-ARYA-16-016){ref-type="table-fn"}**   **WHR \< 0.85 in women**           **WHR ≥ 0.85 in women**           **P[\*](#tfn4-ARYA-16-016){ref-type="table-fn"}**
  **Risk assessment tools**                                                                                                                         Men (n = 1623)                                                                                                           Women (n = 1287)                                                     
  A risk of ≥ 7.5% based on pooled cohort equations of ACC/AHA [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                                          42.27 (38.33-46.21)                63.86 (61.06-66.65)               \< 0.0010                                           10.41 (7.49-13.32)                 32.93 (29.90-35.96)               \< 0.0010
  A risk of ≥ 5% based on SCORE equations for low risk European countries [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                               6.70 (4.74-8.66)                   12.43 (10.55-14.31)               0.0010                                              0.45 (-0.17-1.07)                  2.86 (1.82-3.90)                  0.0340
  A risk of ≥ 5% based on SCORE equations for high risk European countries [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                              16.11 (13.23-18.99)                29.16 (26.57-31.75)               \< 0.0010                                           1.81 (0.57-3.05)                   6.64 (5.08-8.02)                  0.0010
  A risk of ≥ 10% based on the Framingham general cardiovascular risk profile for use in primary care [£](#tfn3-ARYA-16-016){ref-type="table-fn"}   36.80 (32.95-40.65)                61.04 (58.20-63.87)               \< 0.0010                                           6.87 (4.46-9.28)                   28.47 (25.56-31.38)               \< 0.0010
  **Obesity indices (WHtR)**                                                                                                                        **WHtR \< 0.5 in men and women**   **WHtR ≥ 0.5 in men and women**   **P[\*](#tfn4-ARYA-16-016){ref-type="table-fn"}**   **WHtR \< 0.5 in men and women**   **WHtR ≥ 0.5 in men and women**   **P[\*](#tfn4-ARYA-16-016){ref-type="table-fn"}**
  **Risk assessment tools**                                                                                                                         Men (n = 1623)                                                                                                           Women (n = 1287)                                                     
  A risk of ≥ 7.5% based on pooled cohort equations of ACC/AHA [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                                          38.87 (33.56-44.18)                60.38 (57.83-62.93)               \< 0.0010                                           10.45 (3.12-17.77)                 26.64 (24.22-29.06)               0.0030
  A risk of ≥ 5% based on SCORE equations for low risk European countries [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                               6.57 (3.91-9.22)                   11.32 (9.70-12.94)                0.0100                                              0.00 (0.00-0.00)                   2.22 (1.43-3.00)                  0.2080
  A risk of ≥ 5% based on SCORE equations for high risk European countries [£](#tfn3-ARYA-16-016){ref-type="table-fn"}                              15.22 (11.38-19.07)                26.78 (24.52-29.04)               \< 0.0010                                           0.00 (0.00-0.00)                   5.40 (4.19-6.60)                  0.0460
  A risk of ≥ 10% based on the Framingham general cardiovascular risk profile for use in primary care [£](#tfn3-ARYA-16-016){ref-type="table-fn"}   33.31 (28.18-38.44)                57.05 (54.47-59.63)               \< 0.0010                                           7.46 (1.17-13.75)                  22.43 (20.14-24.72)               0.0040

The proportion (percentage) of individuals with a 10-year risk of CVD of ≥ 0.075 for pooled cohort equations, ≥ 0.05 for SCORE equations (both low and high risk countries versions), and ≥ 0.1 for the Framingham general cardiovascular risk profile for use in primary care

Significance level was considered at P \< 0.0500.

BMI: Body mass index; ACC/AHA: American College of Cardiology/American Heart Association; SCORE: Systematic Coronary Risk Evaluation; WC: Waist circumference; WHR: Waist to hip ratio; WHtR: Waist to height ratio; CVD: Cardiovascular disease

###### 

Univariate logistic regression results

  Obesity indices                           Men (n = 1623)                                                                                                                                    Women (n = 1287)                                            
  ----------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ----------- -------- ------------------- -----------
                                            A 10-year CVD risk ≥ 0.075 of pooled cohort equations for ACC/AHA tool[£](#tfn7-ARYA-16-016){ref-type="table-fn"}                                                                                             
  BMI ≥ 30 kg/m^2^ both in men and women    6.50                                                                                                                                              1.34 (1.07-1.69)   0.0110      2.250    0.83 (0.64-1.06)    0.1340
  WC ≥ 102 cm in men and ≥ 88 cm in women   26.92                                                                                                                                             1.89 (1.48-2.40)   \< 0.0010   10.420   1.73 (1.24-2.24)    0.0010
  WHR ≥ 0.9 in men and ≥ 0.85 in women      81.65                                                                                                                                             2.56 (2.08-3.13)   \< 0.0010   63.600   4.12 (2.91-5-83)    \< 0.0010
  WHtR ≥ 0.50 both in men and women         51.47                                                                                                                                             2.47 (1.95-3.16)   \< 0.0010   10.570   5.42 (1.96-15.00)   0.0110
                                            A 10-year CVD risk ≥ 0.050 of SCORE equations for low risk European countries[£](#tfn7-ARYA-16-016){ref-type="table-fn"}                                                                                      
  BMI ≥ 30 kg/m^2^ both in men and women    0.01                                                                                                                                              1.02 (0.72-1.45)   0.9130      0.060    0.91 (0.44-1.89)    0.8030
  WC ≥ 102cm in men and ≥ 88cm in women     3.24                                                                                                                                              1.36 (0.97-1.91)   0.0720      0.380    1.36 (0.51-3.57)    0.5390
  WHR ≥ 0.9 in men and ≥ 0.85 in women      13.94                                                                                                                                             1.98 (1.38-2.83)   0.0020      6.490    6.49 (1.54-27.37)   0.0110
  WHtR ≥ 0.50 both in men and women         6.43                                                                                                                                              1.82 (1.14-2.80)   0.0110      \- \$    \- \$               \- \$
                                            A 10-year CVD risk ≥ 0.050 of SCORE equations for high risk European countries[£](#tfn7-ARYA-16-016){ref-type="table-fn"}                                                                                     
  BMI ≥ 30 kg/m^2^ both in men and women    0.06                                                                                                                                              1.03 (0.81-1.32)   0.8140      0.235    0.89 (0.55-1.43)    0.6280
  WC ≥ 102 cm in men and ≥ 88 cm in women   11.17                                                                                                                                             1.51 (1.19-1.92)   0.0080      0.534    1.26 (0.68-2.32)    0.4650
  WHR ≥ 0.9 in men and ≥ 0.85 in women      36.60                                                                                                                                             2.14 (1.68-2.75)   \< 0.0010   12.722   3.87 (1.84-8.13)    0.0040
  WHtR ≥ 0.50 both in men and women         19.03                                                                                                                                             2.04 (1.48-2.80)   \< 0.0010   \- \$    \- \$               \- \$
                                            A 10-year CVD risk ≥ 0.100 of Framingham general cardiovascular risk profile for use in primary care[£](#tfn7-ARYA-16-016){ref-type="table-fn"}                                                               
  BMI ≥ 30 kg/m^2^ both in men and women    9.33                                                                                                                                              1.41 (1.13-1.76)   0.0020      0.010    1.01 (0.78-1.32)    0.9180
  WC ≥ 102 cm in men and ≥ 88 cm in women   33.79                                                                                                                                             1.98 (1.57-2.50)   \< 0.0010   17.750   2.25 (1.54-3.27)    \< 0.0010
  WHR ≥ 0.9 in men and ≥ 0.85 in women      90.41                                                                                                                                             2.69 (2.19-3.30)   \< 0.0010   67.160   5.40 (3.61-8.08)    \< 0.0010
  WHtR ≥ 0.50 both in men and women         57.01                                                                                                                                             2.66 (2.06-3.43)   \< 0.0010   7.400    3.59 (1.43-9.01)    \< 0.0010

Significance level was considered at P \< 0.0500.

outcomes are a 10-year risk of CVD ≥ 0.075 for pooled cohort equations, ≥ 0.05 for SCORE equations (both low and high risk countries versions), and ≥ 0.1 for the Framingham general cardiovascular risk profile for use in primary care.

\$ No women with WHtR \< 0.5 had a 10-year risk of CVD ≥ 0.05 based on SCORE equations (based on both high and low risk European countries).

OR: Odd ratio; CI: Confidence interval; CVD: Cardiovascular disease; ACC/AHA: American College of Cardiology/American Heart Association; BMI: Body mass index; WC: Waist circumference; WHR: Waist to hip ratio; WHtR: Waist to height ratio; SCORE: Systematic Coronary Risk Evaluation
